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ABSTRACT
Many infants are nurtured with milk supplied by human banks, whose bacteriological 
and physical-chemical profiles are a major issue. We investigated the bacteriological and 
physical-chemical characteristics, as well as genotypic and phenotypic and profiles of 
Staphylococcus species isolated from 240 samples of breast milk from a bank in a teaching 
hospital. Dornic acidity of milk revealed that 95.4% (229/240) had acceptable limits 
(< 8.0 oD). Caloric intake showed a wide variation in cream content (4%), fat (4%) and energy 
values (559.81 Kcal/L). Staphylococcus (105/186 or 56.5%) and Enterobacter (25/186 or 
13.4%) were the most prevalent genera, although other microorganisms were identified, 
including Klebsiella  pneumoniae and Pseudomonas aeruginosa. Amoxicillin/clavulanic 
acid (125/157 or 79.6%), vancomycin (115/157 or 73.2%), and cephalexin (112/157 or 
71.3%) were the most effective antimicrobials. High resistance rates of isolates were found 
to penicillin G (141/157 or 89.8%), ampicillin (135/157 or 86%), and oxacillin (118/157 or 
75.2%). Multidrug resistance to ≥ 3 antimicrobials occurred in 66.2% (123/186) of the isolates. 
Residues of microbial multiplication inhibitory substances were found in 85% (204/240) of 
samples. Among the coagulase-positive-CPS and negative-CoNS staphylococci, the mecA 
gene was detected in 53.3% (8/15) and 75% (30/40), respectively. Genes sea, seb and sec 
were detected in 20% (3/15) of CPS, while tsst-1 was detected in 13.34% (2/15). In addition, 
13.3% (2/15) of S. aureus were toxin-producers. Genes sea, seb and sec were detected in 90% 
(36/40), 5% (2/40) and 15% (6/40) CoNS, respectively. Enterotoxin production was identified 
in 5% (2/40) of CoNS. The identification of multidrug-resistant bacteria, staphylococci 
species toxin-producers harboring methicillin-resistance genes, and residues of microbial 
multiplication inhibitory substances reinforce the need for a continuous vigilance of milk 
quality offered to infant consumption by human banks.
KEYWORDS: Neonatal milk. Human milk banks. Breastfeeding. Multidrug-resistant 
bacteria. Staphylococcal toxins.
INTRODUCTION
Human breast milk is recognized as the primary source of nutrition and of organic 
defense for newborns. Breastfeeding is recommended at least during the first six 
months of life and should be encouraged until two years of age1. 
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Breastfeeding is also well-known as a means of 
strengthening the bond between mother and child, and 
it is able to influence psychological and emotional 
conditions2.
Human milk banks are usually located in maternal or 
pediatric hospitals. These banks are responsible for the 
promotion and encouragement of breastfeeding and also 
for collection, processing and quality control of colostrum, 
transitional and mature milk, and distribution, upon 
prescription by the attendant physicians3,4. They guarantee 
the supply of milk as the first food option for preterm 
infants, contributing to the prevention of neonatal diseases 
and reducing infant’s mortality, especially of those who did 
not have access to their mothers’ milk5.
The quality of milk supplied by the human milk banks 
has been investigated worldwide, particularly regarding 
the microbial profile, the resistance of microorganisms 
to antimicrobials used in medical practice, and the 
pasteurization procedure to improve the collection and 
storage of milk offered in human banks2-4,6-8.
The microbiological profile of human milk is a major 
issue, as breast milk may contain commensal bacteria that 
are important to establish the enteric microbiota of neonates 
in the first days of life, e.g., staphylococci, streptococci, 
corynebacterium species and lactic acid producing bacteria9. 
Nonetheless, these bacteria may act as a reservoir of 
antibiotic resistant genes, which are similar to those reported 
in pathogenic bacteria10. 
 Staphylococci are well-known gram-positive bacteria 
that can be found as an inhabitant of the skin, mucosa 
(urogenital, upper respiratory tract), and conjunctive 
microbiota of humans and animals, and that may also 
be related to different clinical infections11. Studies that 
investigated the microbiota of human breast milk of healthy 
mothers and bank donors have reported a predominance of 
Staphylococcus species among isolated bacteria3,10,12. 
On a global level, the multidrug-resistant bacteria 
originated from humans and domestic animals are an 
emergent public health concern13. A set of mechanisms 
and genes related to antimicrobial resistance have 
been described in different bacteria. Particularly 
among staphylococci strains, including Staphylococcus 
aureus and coagulase-negative staphylococci (CoNS), 
the mecA gene has been used to predict methicillin 
resistance14 and provide initial support in therapeutic 
decision-making15. 
Antimicrobials have been indicated in the treatment 
of puerperal mastitis or used in pre- and postpartum 
prophylaxis as well as in caesarean sections, belonging 
mainly to the group of first and second-generation 
penicillins and cephalosporins. These drugs are considered 
safe during lactation because of the small number of 
antibiotic-derived residues excreted in milk due to the 
high binding rate with maternal plasma proteins. The 
presence of chemical residues, especially those from 
antimicrobials in breastfeeding milk has been a concern 
for humans16, reinforcing that a continuous vigilance 
of microbiological and physicochemical conditions of 
milk offered to infants is necessary in human banks4. In 
this scenario, we investigated the bacteriological quality, 
physical-chemical characteristics, the presence of residues 
of microorganism-inhibiting substances in human breast 
milk, as well as toxin-producers and multidrug-resistance 




This study was approved by the Ethics Committee, 
Veterinary Medicine and Animal Sciences, UNESP, 
Botucatu, Sao Paulo, Brazil (protocol Nº 037/11).
Breast milk samples
Two hundred and forty samples of raw human milk were 
conveniently sampled4,5 from the routine of microbiological 
and physicochemical analysis of raw breast milk weekly 
sent to the Food Inspection Laboratory, at the School 
of Veterinary Medicine and Animal Sciences, UNESP/
Botucatu, Sao Paulo, Brazil, from a human milk bank in 
a Teaching Hospital located on the center of Sao Paulo 
State, Brazil. The milk was collected between 8-15 days 
after delivery, avoiding the colostrum period. Samples were 
subjected to microbiological and physicochemical tests and 
then, pasteurized and stored at temperatures between -21 °C 
and -10 °C. The human milk bank followed the guidelines 
of the Brazilian Human Milk Banks Network17. The identity 
of donors was maintained anonymous. 
Dornic acidity and crematocrit analyses
Dornic acidity was determined as previously described 
using 4 mL of breast milk. Values accepted by the Brazilian 
human milk bank network comprise the range of 1-8 oD. 
The crematocrit of milk samples, used to evaluate the cream 
content, total fat and energy value was carried out based 
on standardized method18, using the following calculation: 
cream content: cream column (mm) x 100 ÷ total column 
(mm) = cream%; Fat content: (cream% - 0.59) ÷ 1.46 = fat %; 
Total energy content: (cream% x 66.8 + 290) = Kcal/L.
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Bacterial identification
Milk samples were plated on 5% sheep blood agar and 
MacConkey agar, maintained under aerobic conditions at 
37 °C, for 72 h. The isolates were identified according to 
conventional phenotypic features. The suggestive colonies 
of staphylococci were stained by the gram method and 
isolates presenting with grouped gram-positive cocci were 
subjected to coagulase tests to identify coagulase-positive 
(CPS) and coagulase-negative (CoNS) isolates11. 
Fermentation tests of maltose, trehalose and mannitol 
sugars, resistance to polymyxin B (300 IU), and acetoin 
production were carried out to identify S. aureus species in 
addition to other CPS11. The differentiation among CoNS 
species was performed using a modified method described 
previously19. All isolates were stored in tubes containing 
nutrient broth and glycerol (5%) and they were kept at 
-20 °C.
In vitro antimicrobial susceptibility pattern
Microorganisms were subjected to in vitro antimicrobial 
susceptibility test by the standard disk diffusion method20, 
using 11 antimicrobials from six different classes, 
as follow: 1) penicillin and derivatives (amoxicillin/
clavulanic acid 10/20 µg, ampicillin 10 µg, oxacillin 5 µg, 
penicillin 10 IU), 2) cephalosporins (cephalexin 30 µg, 
cefoxitin 30 µg), 3) macrolides (erythromycin 15  µg), 
4) aminoglycosides (gentamicin 10 µg, neomycin 30 µg), 
5) sulphonamides (trimethoprim/sulfamethoxazole 25 µg), 
and 6) glycopeptides (vancomycin 30 µg). Multidrug-
resistant bacteria were considered when there was 
simultaneous resistance to three or more classes of the 
tested antimicrobials21. 
Phenotypic identification of methicillin-resistant 
Staphylococcus (MRS) and the minimum inhibitory 
concentration (MIC)
The susceptibility testing using oxacillin (1 µg) and 
cefoxitin (30 µg) discs was performed by the agar diffusion 
technique to MRS. All CPS and 40 CoNS randomly selected 
were submitted to the phenotypic investigation of MRS. 
MIC was determined also by the agar diffusion technique, 
using oxacillin strips (0.016 - 0.256 µg/µg)20.
Identification of microbial multiplication inhibitors in 
milk
The presence of microbial multiplication inhibitors 
in breast milk was evaluated using a commercial 
kit (DelvotestTM, DSM Food Specialties, Delft, The 
Netherlands)22 according to the manufacturer’s standards. 
This qualitative test is based on the change of colors and 
can identify >10 ng/mL of the tested classes/antimicrobials: 
beta-lactams (penicillin-G, ampicillin, amoxicillin, 
cefacetrile, cefalexin, cefalonium, cefoperazone, 
cefapirin, ceftiofur, cloxacillin, dicloxacillin, oxacillin, 
nafcillin), sulphonamides (sulfadiazine, sulfadimethoxine, 
sulfamethazine, sulfathiazole), tetracyclines (tetracycline, 
oxytetracycline,  chlortetracycline),  macrolides 
(erythromycin, tylosin, spiramycin), aminoglycosides 
(gentamycin, neomycin, dihydrostreptomycin, kanamycin), 
lincosamides (lincomycin), amphenicols (chloramphenicol), 
and dihydropyrimidine (trimethoprim).
Genotypic detection of resistance and toxin genes
DNA extraction was performed from CPS and CoNS 
using a commercial kit (IllustraTM, Blood GenomicPrep 
MiniSpin, G.E. Healthcare Life Sciences, USA), according 
to the manufacturer’s instructions. DNA samples were 
stored at -20 °C. The detection of methicillin-resistant 
isolates (MRS) was based on the polymerase chain reaction 
(PCR) results23. S. aureus ATCC 33591 was used as a 
positive control (MRSA) and S. aureus ATCC 25923 as a 
negative control (susceptible strain).
Amplifications were carried out as described previously19 
to investigate the genes encoding the enterotoxins SEA, 
SEB, SEC and SED, and the toxic shock syndrome toxin 1 
(TSST-1). S. aureus ATCC 13565, ATCC 14458, ATCC 
19095, ATCC 23235 and ATCC 51650 were used as positive 
controls for sea, seb, sec, sed, and tsst-1 genes, respectively. 
Sterile water was used as a negative control.
Phenotypic detection of toxin production
S. aureus, other CPS and CoNS-positive for toxin-
encoding genes were subjected to phenotypic tests to evaluate 
gene expression. The production of enterotoxins A, B, C, 
D and toxic shock syndrome 1 toxin (TSST-1) in S. aureus 
strains was investigated using the cellophane-over-agar24. 
The sac culture method was used for CoNS and CPS 
(except S. aureus) to produce large amounts of SEA, SEB, 
SEC, SED and TSST-1 toxins. Later, the detection of the 
extracellular product was performed using a rapid reversed 
passive latex agglutination (RPLA)25 test. Subsequently, the 
detection of enterotoxins A, B, C, and D was based on the 
SET-RPLA toxin commercial kit (OxoidTM, Waltham, USA) 
results and TSST-1 by the TSST-RPLA Toxin Detection kit 
(OxoidTM, Waltham, USA) following the manufacturer’s 
instructions.
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Statistical analysis
The 95% confidence interval (CI) for both positive and 
negative samples was calculated based on the absolute and 
relative frequencies of isolation of microorganisms from 
milk samples. The association between the microbiological 
profile, the acidity values and the presence of microbial 
multiplication inhibitors were compared with each other 
using the appropriate tests in each case, i.e., Chi-square 
(χ2), Fisher’s exact and Williams G tests. The phenotypic 
and genotypic comparison between methicillin and/or 
oxacillin resistant CPS and CoNS versus the detection of 
toxin encoding genes was analysed using the Fisher exact 
test or the χ2, with a level of significance set at 0.05.
RESULTS
Acidity and crematocrit
Data on titrated Dornic acidity (oD) ranged from 2.5 oD 
to 12.5 oD, as follow: 2.5 oD (107/240 or 44.6%), 5.0 oD 
(102/240 or 42.5%), 7.5 oD (20/240 or 8.3%), 10.0 oD 
(6/240 or 2.5%), 12.5 oD (5/240 or 2.1%). Of these, 95.4% 
(229/240) of milk samples had titratable acidity < 8.0 oD 
and only 4.6% (11/240) had titratable acidity > 8.0 oD. 
Cream, fat, and energy content
The average (minimum and maximum value) of cream, 
fat and energy content among the 240 milk samples was 
4.0% (1.54-11.3%), 2.4% (0.65-7.3%) and 55.8 Kcal/L 
(392.8-1,044.19 Kcal/L), respectively. 
Identification of microorganisms
One hundred and eighty-sixth bacteria and yeast were 
isolated among the 240 samples of human breast milk. 
Staphylococcus (105/186 or 56.5%), Enterobacter (25/186 
or 13.4%), and Bacillus (22/186 or 11.8%) were the most 
frequent genera isolated (Table 1). Other microorganisms 
were less frequently identified, e.g., Klebsiella pneumoniae 
(03/186 or 1.6%), Pseudomonas aeruginosa (03/186 
or 1.6%), Hafnia alvei (02/186 or 1.1), and Klebsiella 
oxytoca (1/186 or 0.5%). Enterobacteria, i.e., Enterobacter 
sp., Klebsiella pneumoniae, Hafnia alvei and Klebsiella 
oxytoca, represented 16.6% of the isolates.
Among 105 staphylococci isolates, 14.3% (15/105) 
were classified as CPS and 85.7% (90/105) as CoNS. Only 
4.7% (5/105) were identified as S. aureus. Among CoNS, 
S. epidermidis was the most frequent species (75/105 or 
71.4%) (Table 2). 
No isolation of microorganisms was observed in 40% 
(96/240) of milk samples.
In vitro antimicrobial susceptibility test
Amoxicillin/clavulanic acid (125/157=79.6%), 
vancomycin (115/157=73.2%) and cephalexin 
(112/157=71.3%) were the most effective antimicrobial 
agents against isolates (Table 3). High resistance rates 
were found to penicillin G (141/157 or 89.8%), ampicillin 
(135/157 or 86%) and oxacillin (118/157 or 75.2%) 
Table 1 - Microorganisms isolated from 240 samples of human 
milk in a Teaching Hospital from Sao Paulo State, Brazil.
Microorganisms
Number of isolates / total of 
isolates (%)
Staphylococcus sp. 105/186 (56.5)
Enterobacter sp. 25/186 (13.4)
Bacillus sp. 22/186 (11.8)
Streptococcus sp. 09/186 (4.8)
Acinetobacter sp. 08/186 (4.3)
Yeast 07/186 (3.8)
Klebsiella pneumoniae 03/186 (1.6)
Pseudomonas aeruginosa 03/186 (1.6)
Hafnia alvei 02/186 (1.1)
Klebsiella oxytoca 01/186 (0.5)
Micrococcus sp. 01/186 (0.5)
Total 186/186 (100)
Table 2 - Species characterization of coagulase-positive 
staphylococci (CPS) and coagulase-negative staphylococci 
(CoNS) in 105 staphylococcal isolates obtained from 240 milk 
samples in a Teaching Hospital from Sao Paulo State, Brazil.
Species
Number/ total of 
staphylococci isolates (%)
CPS
Staphylococcus spp. 10/105 (9.5)
S. aureus 05/105 (4.8)
Subtotal 15/105 (14.3)
CoNS
S. epidermidis 75/105 (71.4)
S. saprophyticus 06/105 (5.7)
Staphylococcus spp. 04/105 (3.8)
S. simulans 02/105 (1.9)
S. xylosus 02/105 (1.9)
S. lugdunensis 01/105 (0.9)
Subtotal 90/105 (85.7)
Total 105/105 (100)
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(Table 3). Particularly to staphylococci isolates, vancomycin 
(105/105 or 100%), amoxicillin/clavulanic acid (100/105 or 
95.2%), and cephalexin (98/105 or 93.3%) were the most 
effective antimicrobials. Simultaneous resistance to three or 
more classes of antimicrobials tested (multidrug-resistance) 
was found in 66.2% (123/186) of all bacterial isolates.
All 15 CPS isolates were subjected to the phenotypic 
investigation of MRS. From these, 33.3% (5/15) were 
resistant to oxacillin and/or cefoxitin, whereas 93.3% 
(14/15) were resistant to penicillin. Only one (1/15 or 
6.7%) Staphylococcus strain presented with a simultaneous 
resistance to oxacillin, penicillin and oxacillin (discs and 
strip). Out of 40 (40/90 or 44.4%) CoNS subjected to the 
phenotypic investigation of MRS, 67.5% (27/40) showed 
resistance to oxacillin and/or cefoxitin, while 95% (38/40) 
revealed resistance to penicillin. Using the oxacillin strip, 
the resistance of isolates was observed in 45% (18/40) of 
CoNS (Table 4).
When comparing the occurrence of methicillin resistance 
between CPS and CoNS isolates using phenotypic methods 
(AST and MIC), a statistically significant difference 
(p<0.05) was found only for the MIC test with oxacillin 
Table 3 - In vitro antimicrobial susceptibility pattern of bacteria isolated from 240 samples of human milk in a Teaching Hospital 





Gentamicin 96/157 (61.2) 9/157 (5.7) 52/157 (33.1)
Neomycin 56/157 (35.7) 61/157 (38.8) 40/157 (25.5)
Cephalosporins
Cefoxitin 66/157 (42) 5/157 (3.2) 86/157 (54.8)
Cephalexin 112/157 (71.3) 6/157 (3.8) 39/157 (24.9)
Glycopeptides Vancomycin 115/157 (73.2) 0/157 (0) 42/157 (26.8)
Macrolides Erytromycin 20/157 (12.7) 43/157 (27.4) 94/157 (59.9)
Penicillin G and derivatives
Amoxacillin/clavulanic acid 125/157 (79.6) 5/157 (3.2) 27/157 (17.2)
Ampicillin 21/157 (13.4) 1/157 (0.6) 135/157 (86)
Oxacillin 36/157 (22.9) 3/157 (1.9) 118/157 (75.2)
Penicillin G 15/157 (9.6) 1/157 (0.6) 141/157 (89.8)
Sulfonamides Trimethoprim/sulfamethoxazole 103/157 (65.6) 6/157 (3.8) 48/157 (30.6)
Table 4 - Phenotypic and genotypic identification of methicillin-resistant Staphylococcus (MRS) isolated from samples of human 
milk in a Teaching Hospital from Sao Paulo State, Brazil. 
AST Cefoxitin AST Oxacillin AST Penicillin MIC Oxacillin PCR mecA
n/T (%) n/T (%) n/T (%) n/T (%) n/T (%)
CPS
S. aureus 01/15 (6.67) 02/15 (13.33) 05/15 (33.33) 0/15 (0) 02/15 (13.33)
Staphylococcus spp. 02/15 (13.33) 03/15 (20) 09/15 (60) 1/15 (6.67) 06/15 (40)
Total 03/15 (20) 05/15 (33.33) 14/15 (93.33) 1/15 (6.67) 08/15 (53.33)
CoNS
S. epidermidis 13/40 (32.50) 16/40 (40) 25/40 (62.50) 12/40 (30) 22/40 (55)
S. lugdunensis 0/40 (0) 0/40 (0) 01/40 (2.50) 01/40 (2.50) 0/40 (0)
S. saprophyticus 03/40 (7.50) 04/40 (10) 05/40 (12.50) 02/40 (5) 03/40 (7.50)
S. simulans 01/40 (2.50) 01/40 (2.50) 02/40 (5) 01/40 (2.50) 02/40 (5)
S. xylosus 01/40 (2.50) 01/40 (2.50) 02/40 (5) 02/40 (5) 01/40 (2.50)
Staphylococcus spp. 03/40 (7.50) 02/40 (5) 03/40 (7.50) 0/40 (0) 02/40 (5)
Total 21/40 (52.50) 24/40 (60) 38/40 (95) 18/40 (45) 30/40 (75)
AST = antimicrobial susceptibility testing by the disk diffusion method; MIC = minimal inhibitory concentration; PCR = polymerase 
chain reaction; mecA = gene encoding methicillin resistance; n = number of isolates; T = total of isolates; CPS = Coagulase-positive 
staphylococci; CoNS = Coagulase-negative staphylococci.
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(p=0.0268). There was no significant difference in bacterial 
resistance between CPS and CoNS isolates to cefoxitin 
(p=0.774), oxacillin (p=0.1529) and penicillin (p=0.6234).
Microbial multiplication inhibitors in milk
Among all samples of human milk, 85% (204/240) 
revealed the presence of microbial multiplication inhibiting 
substances.
Genotypic detection of methicillin resistance gene 
(mecA)
The mecA gene was detected in 53.3% (8/15) of CPS. 
Among CPS strains, in 46.7% (7/15) there was no gene 
detection. Of these, 28.7% (2/7) of CPS-negative for mecA 
gene showed resistance to oxacillin and/or cefoxitin, and 
also to penicillin.
From CoNS, the gene mecA was detected in 75% (30/40) 
isolates, being 55% (22/40) S. epidermidis. In 25% (10/40) 
of CoNS, no mecA gene was detected, although 20% (2/10) 
were resistant to oxacillin in the MIC test. There was no 
significant difference (p=0.1122) between CPS and CoNS 
isolates regarding the detection of mecA gene.
Molecular identification of the genes and staphylococcal 
toxins
The sea, seb and sec genes were detected in 20% (3/15) 
of the CPS isolates. The tsst-1 gene was identified in 13.3% 
(2/15). The simultaneous occurrence of two or more of these 
genes was found in 26.7% (4/15) of CPS isolates. Of the 
15 CPS isolates, 13.3% (2/15) S. aureus were phenotypic 
toxin-producers. From these, 6.7% (1/15) produced SEA 
and TSST-1, and another isolate SEA and SEC, although 
also harbouring the seb gene. The sea gene was detected in 
90% (36/40) of CoNS. In only 5% (2/40) of these isolates, 
the seb and sec genes were detected. Enterotoxin D and 
TSST-1 toxin-encoding genes were not identified among 
CoNS isolates (Table 5).
The occurrence of two or more genes was found in 
17.5% (7/40) of CoNS. The association of sea and sec genes 
occurred in 12.5% (5/40) of CoNS isolates. The sea and seb 
genes were identified in 5% (2/40). Enterotoxin production 
was detected in 5% (2/40). From these, S. saprophyticus 
was a SEA toxin-producer, while Staphylococcus spp. of 
SEB toxin-producer (Table 6). 
Comparing CPS and CoNS isolates for the presence of 
encoding genes for staphylococcal toxins, the statistically 
significant difference (p <0.0001) was found only for the 
sea gene.
DISCUSSION
In this study, we identified a complexity of microorganisms, 
multidrug-resistant bacteria, and staphylococci species 
toxin-producers harboring methicillin-resistance genes, as 
well as the presence of microbial multiplication inhibiting 
substances, among human breast milk samples intended for 
newborns’ consumption in a teaching hospital, in Brazil. 
The physicochemical and microbiological characteristics 
of the human milk distributed to human milk banks are 
Table 5 - Toxin genes of staphylococci identified in human milk from a bank in a Teaching Hospital from Sao Paulo State, Brazil.
Genes
sea seb sec sed tsst-1
n/T (%) n/T (%) n/T (%) n/T (%) n/T (%)
CPS
S. aureus 2/15 (13.3) 1/15 (6.7) 2/15 (13.3) 0/15 (0) 1/15 (6.7)
Staphylococcus spp. 1/15 (6.7) 2/15 (13.3) 1/15 (6.7) 0/15 (0) 1/15 (6.7)
Total 3/15 (20) 3/15 (20) 3/15 (20) 0/15 (0) 2/15 (13.3)
CoNS
S. epidermidis 22/40 (55) 0/40 (0) 4/40 (10) 0/40 (0) 0/40 (0)
S. lugdunensis 1/40 (2.5) 0/40 (0) 0/40 (0) 0/40 (0) 0/40 (0)
S. saprophyticus 5/40 (12.5) 1/40 (2.5) 1/40 (2.5) 0/40 (0) 0/40 (0)
S. simulans 2/40 (5) 0/40 (0) 0/40 (0) 0/40 (0) 0/40 (0)
S. xylosus 2/40 (5) 0/40 (0) 0/40 (0) 0/40 (0) 0/40 (0)
Staphylococcus spp. 4/40 (10) 1/40 (2.5) 1/40 (2.5) 0/40 (0) 0/40 (0)
Total 36/40 (90) 2/40 (5) 6/40 (15) 0/40 (0) 0/40 (0)
N = number of isolates; T = total of isolates; sea = gene fencoding enterotoxin A; seb = gene encoding enterotoxin B; sec = gene 
encoding enterotoxin C; sed = gene encoding enterotoxin D; tsst-1 = gene encoding toxic shock syndrome toxin 1; CPS = Coagulase-
positive staphylococci; CoNS = Coagulase-negative staphylococci.
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matters of great impact on human health, as this food is 
essential for newborns in the first days of life, requiring a 
continuous vigilance of quality.
Acidity levels in Dornic degrees (ºD) and the crematocrit 
of human breast milk are well-known main physicochemical 
parameters26,27. Milk is a buffer system with a low 
concentration of free hydrogen ions. The acidity of human 
milk can be classified as original and developed. The term 
original results from the presence of its constituents (micelles 
of casein and mineral salts, among which phosphates and 
citrates stand out), whereas the developed is a consequence 
of the bacterial growth, from the primary and secondary 
microbiota, with the production of lactic acid26. In the 
current study, 95.4% of human milk samples had titratable 
acidity < 8.0 ºD. Likewise, a large-scale comprehensive 
study with 4,204 human milk samples revealed 91.40% 
of samples with titratable acidity < 8.0 ºD27, values within 
the acceptable range, between 1.0-8.0 ºD, recommended by 
the Brazilian human milk banks network17. However, it is 
reasonable to state that breast milk samples with titratable 
acidity < 8.0 ºD should be pasteurized to eliminate the 
pathogenic microorganisms, as opposed to milk samples 
with titratable acidity ≥ 8.0 ºD that should be discarded17,18. 
Increasing acidity at levels ≥ 7.0 ºD may be related to 
inadequate conditions of transport and storage of breast 
milk. The progressive increase of temperature stimulates 
fermentative action and enzyme production by bacteria 
present in milk, determining the degradation of triglycerides 
and increasing the concentrations of hydrogen ions, which 
lead to the reduction of pH and increase of the titratable 
acidity28. These abnormalities result in a significant decrease 
in the quality of breast milk provided to newborns.
The caloric intake of breast milk sampled revealed 
variations of 11.29 ± 1.54% for cream content, 7.33 ± 0.65% 
for fat, and 1044.19 ± 392.77 Kcal/L of total energy value. 
The variation of fat content can be attributed to a number 
of factors, including the stage in the lactation cycle, genetic 
individuality, nursing mother’s diet and differences between 
ethnic groups29. A study described changes in the mean 
percentage of milk fat collected manually at the beginning 
of the breastfeeding period (2 ± 1.9%), after five minutes 
(9 ± 2.8%), 10 minutes (11.4 ± 4.6%), and at the end of 
breastfeeding (14.3 ± 3.8%), indicating that the phase of 
milk collection may influence the fat content30.
Breast milk can be a pathway for transmission of 
microorganisms to newborns if not handled under appropriate 
hygienic conditions10. The adoption of preventive measures 
reduces operational risks and secondary contamination 
from the environment, utensils, donors and healthcare 
professionals, ultimately providing safe and healthy food 
for infants and children1,17. Physicochemical parameters 
(acidity and crematocrit) of breast milk from the human 
milk bank in the teaching hospital studied here revealed 
within acceptable limits, and satisfactory conditions of milk 
collection from the nursing mothers.
Staphylococcus species are well-known bacteria that 
inhabit mucous membranes, conjunctiva and skin of humans 
and animals11. This group of bacteria has been isolated from 
human breast milk10. In the present study, 56.5% of bacterial 
isolated from breast milk belonged to the staphylococci 
group. These results are consistent with similar studies that 
have also reported the predominance of Staphylococcus 
species in human breast milk3,10,12.
Among the CoNS and CPS species identified in 
the current study, S. epidermidis (71.4%) was the most 
prevalent, whereas S. aureus was responsible for only 4.5% 
of the total staphylococci species. In fact, S. epidermidis has 
been a frequent species isolated from human breast milk, 
probably because it contaminates milk through the maternal 
skin, a natural habitat of this pathogen31.
Table 6 - Mono- and co-occurrence of toxin genes and toxin production in coagulase-positive staphylococci (CPS) and coagulase-





sea + seb/SEA + SEB 0/0 2/0
sea + sec/SEA + SEC 0/1 5/0
sea + tsst-1/SEA + TSST-1 2/1 0/0
sea + seb + sec/SEA + SEB + SEC 1/0 0/0
sea + seb + sec + tsst-1/SEA + SEB + SEC + TSST-1 0/0 0/0
seb + sec/ SEB + SEC 0/0 0/0
sea = gene encoding enterotoxin A; SEA = enterotoxin A; seb = gene encoding enterotoxin B; SEB = enterotoxin B; sec = gene encoding 
enterotoxin C; SEC = enterotoxin C; tsst-1 = gene encoding toxic shock syndrome toxin 1; TSST-1 = toxic shock syndrome toxin 1.
Salerno et al.
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Apart from staphylococci and streptococci groups, 
other miscellaneous microorganisms were identified in 
the breast milk sampled, including Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Hafnia alvei, Klebsiella oxytoca, 
as well as Acinetobacter, Micrococcus genus and yeast. 
This finding reinforces the diversity of commensal and 
potentially pathogenic microorganisms that can contaminate 
breast milk3, and the importance of adopting best practices 
to limit the contamination of milk donors4,5.
Coliform bacteria are considered one of the main 
indicators of microbial contamination, as they are relatively 
simple pathogens to isolate using standardized and easy-
to-perform, economically viable and safe methods17,18. 
In the current study, 16.6% of the isolates belong to 
the Enterobacteriaceae family, including Klebsiella 
pneumoniae, Klebsiella oxytoca, Hafnia alvei, and 
Enterobacter genus. Interestingly, there was no isolation 
of E. coli in the current study, a fact that deserves attention 
because this microorganism is considered the main indicator 
of milk contamination17,18. Nevertheless, the presence 
of a complexity of microorganisms in the milk of the 
sampled nursing donors, particularly enterobacteria and 
staphylococci species, indicates the need for a continuous 
vigilance to prevent microbial contamination of breast 
milk, which may occur from a variety of sources, including 
human skin and/or gut, utensils used for milk collection and 
contaminants from the environment3,4.
No isolation of microorganisms was observed in 40% of 
the sampled human breast milk which is in line with other 
studies that have also reported the absence of isolation of 
bacteria in a variable number of samples from donors3,10. 
The high frequence of samples with no isolation of bacteria 
in the current study could be attributed to the best practices 
adopted in breast milk sampling to limit contamination4,5, 
as well as the fact that samples were collected from 
experienced donors, which have been frequently sampled 
over many years in the same teaching hospital. 
The improper use of antimicrobials may increase the 
selective pressure on bacteria to become resistant21. In 
fact, the emergence of multidrug-resistant bacteria from 
humans and animals is a public health concern worldwide13. 
Here, amoxicillin/clavulanic acid (79.6%), vancomycin 
(73.2%), and cephalexin (71.3%) were the most effective 
antimicrobials against all isolates. These drugs have been 
recommended to pregnant women due to their low residual 
excretion and few toxic adverse effects on neonates at 
therapeutic doses16. Nonetheless, there are few data related 
to the use of vancomycin in pregnant or lactating women 
and the occurrence of undesirable reactions, because 
the indication of this antimicrobial is restricted to cases 
of penicillin allergy, and multidrug bacterial resistance, 
mainly to erythromycin and clindamycin32. In turn, high 
resistance rates of isolates obtained from sampled donors 
were found to penicillin G (89.8%), ampicillin (86%) and 
oxacillin (75.2%). In addition, multidrug-resistance for ≥3 
antimicrobials were observed in 66.2% of the isolates. The 
resistance profile of our isolates obtained from breast milk 
agrees with similar studies, where bacterial resistance has 
been reported predominantly to beta-lactam antibiotics, 
especially ampicillin and penicillin33,34. The high occurrence 
of bacterial resistance to the beta-lactam group may be 
attributed to the prophylactic use of pre- and postpartum 
antibiotics, caesarean procedures and self-medication of 
donors16, which may contribute to the increase of selective 
pressure on bacteria to become resistant for this group of 
drugs, reinforcing the importance of the rational use of 
antimicrobials during gestation and post-partum periods.
Delvotest™ is an easy and fast commercial test 
standardized to identify the presence of microbial 
multiplication inhibiting substances in bovine milk. The 
presence of a set of antimicrobials such as beta-lactams, 
sulphonamides, tetracyclines, macrolides, aminoglycosides, 
lincosamides, amphenicols and dihydropyrimidine classes 
(groups) may be identified in milk22, because the improper 
use of antibiotics may increase the selective pressure on 
bacteria to become resistant, as well as residues of the 
drugs in milk may cause disorders in humans16. Among 
the 240 human milk samples, 85% revealed the presence of 
microbial multiplication inhibiting substances when tested 
by the commercial test (Delvotest™). This finding may be 
related to the preventive use of antibiotics to treat pre- and/or 
postpartum infections (e.g., cesarean procedures)34, by 
the improper use of drugs by nursing mothers16, or even 
secondary to the ingestion of products and derivatives 
from animal origin containing antimicrobial residues13. 
Nevertheless, the scarce information of antimicrobial 
residues or inhibitory substances in the breast milk of 
human banks indicates that similar studies should be 
conducted to investigate these substances in milk intended 
for neonatal consumption and their implications for 
infants. Furthermore, the test used in the current study is 
qualitative, standardized for bovines, and does not quantify 
the concentration of antimicrobials, a fact that may be 
considered a limitation of the study.
Phenotypic identification (disk diffusion method) 
has shown a variable association when compared to the 
detection of mecA gene in staphylococci isolated from milk 
samples6,14,15. In this regard, a bacteriological study of 500 
human milk samples from five human milk banks recovered 
171 S. aureus, of which 57 (11.4%) presented with 
methicillin-resistance and high resistance to oxacillin35. In 
the current study, among 240 milk samples, around 30% 
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of Staphylococcus isolates revealed resistance to cefoxitin 
and/or oxacillin and approximately 90% to penicillin using 
the disc diffusion test, whereas the mecA gene was detected 
in 53% of the isolates based on the molecular method. In 
addition, among the 40 CoNS investigated here, 70% were 
resistant to cefoxitin and/or oxacillin, and 95% resistant to 
penicillin using the disc diffusion method, while the mecA 
gene was detected in 75% of CoNS. These results reinforce 
that, in some cases, it is possible to detect genes related to 
antimicrobial resistance without phenotypic expression36. 
Staphylococcus species are well-known by the ability 
to produce toxins and cause food-related diseases6,11. 
The occurrence of puerperal mastitis, the colonization 
of the milk by commensal microorganisms, including 
staphylococci species, and the contamination of utensils 
during the collection or the storage of breast milk have been 
related to risk factors for the transmission of staphylococci 
species by milk to infants3,14. In fact, the presence of 
Staphylococcus species with toxigenic potential has been 
previously described in milk from healthy mothers6,14,31. A 
study involving bacteriological culture of breast milk of nine 
healthy mothers and ten presenting with clinical signs of 
mastitis revealed S. aureus in 13 milk samples. From these, 
eight revealed enterotoxins using the latex agglutination 
method, while SEA, SEB, SEC and TSST-1 were detected 
in three coagulase-positive staphylococci isolates, and SEA 
and SEB in five CoNS strains37. In the current study, among 
the 15 isolates of CPS, the sea, seb, sec, and tsst-1 genes 
were found. The association of two or more genes was 
observed in 26.7% of the isolates. Two isolates produced 
staphylococcal toxins, one of which produced SEA and 
TSST-1, and another SEA and SEC. The detection of toxins 
in staphylococcal strains recovered from breast milk donors 
is an important concern, particularly because sec genes may 
resist to the heat treatment, i.e., pasteurization, and these 
potential reservoirs of staphylococcal toxin-producers may 
be transmitted to infants6.
CoNS are commensal inhabitants of skin and have been 
recognized as a less pathogenic group of bacteria13. This 
group of bacteria have been increasingly reported related 
to hospital and community-acquired infections, and their 
ability to form biofilms has been highlighted, as well as their 
relative resistance to antimicrobials38. However, the impact 
of staphylococci as commensal or potential pathogenic 
bacterial in breast milk is poorly understood. In this way, 
a study involving 54 Staphylococcus strains isolated from 
human milk revealed a high occurrence of CoNS, with 
predominance of S. epidermidis, S. warneri, S. haemolyticus 
and S. aureus37. Here, among the 40 CoNS isolated from 
breast human milk, 90%, 5%, and 15% presented the sea, 
seb and sec genes, respectively, particularly S. epidermidis 
isolates. Moreover, one S. warneri produced SEA and 
another S. simulans produced SEB. Similar to CPS strains6, 
the presence of CoNS may be associated with skin or 
utensils contamination during the collection or the storage 
of breast milk, and detection of strains harboring sec genes 
related to toxin-production is an important matter because 
these genes confer resistance to heat. 
A convenient milk sampling, no speciation by 
MALDI-TOF MS or other automatic system diagnosis 
method of bacterial species, and only around 45% of CoNS 
subjected to the phenotypic investigation of MRS may be 
considered limitations of the current study.
Apart from the well-known nutritional, immunological, 
and psychological benefits of breast-feeding to infants2, in 
the last decades, breastmilk has been recognized as a source 
of commensal and potentially probiotic microorganisms39 
e.g., staphylococci, streptococci, lactic acid producing 
bacteria, which are able to colonize the neonatal gut in 
early life, considered a crucial stage of the neonatal period9. 
Immunomodulatory properties of some bacteria present in 
breast milk could reduce the occurrence of neonatal enteric, 
pulmonary and allergic disorders40. Thus, investigations 
focused on the microbiota of breast milk are important to 
contribute to the health status of neonates.
CONCLUSION
Overall, we identified the presence of microbial 
multiplication inhibiting substances, multidrug-resistant 
bacteria, Staphylococcus isolates harboring methicillin-
resistance genes, which are also toxin-producers, as well as 
a variety of other bacteria in the breast milk from a human 
bank in a teaching hospital in Brazil, highlighting the 
importance of best hygienic practices and the continuous 
vigilance of milk quality offered to infant consumption by 
human banks.
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